Newly qualified pharmacists at LloydsPharmacy will be enrolled on to a 12-month development training programme.
The Department of Health and Social Care has announced the final list of drug price concessions for September.
Pharmaceutical contractor fraud could be costing the NHS in England around £111m each year, according to an NHS England report.
Two companies involved in an investigation into the supply of nortriptyline have confessed to illegal collusion.
The newly launched reusable Respimat inhalers can be used with up to six refill cartridges.
The GPhC said this would improve transparency and “drive improvement in pharmacy services.”
NPA vice-chair Andrew Lane warns the five-year community pharmacy settlement may fail to prevent the closure of pharmacies.
The number of penalty charge notices (PCNs) that are overturned has risen almost twenty-fold in the past five years.
Boots UK has begun trialling an in-store video service giving patients access to GP consultations.
Boots customers in Nottinghamshire and Derbyshire will have their prescriptions delivered by electric vehicles.
The new dispensing facility will eventually assemble around 16 million repeat prescriptions a year for the Rowlands group.
Questions remain over how much funding LPCs will receive to allow pharmacists in their areas to take part in PCNs.
LloydsPharmacy has launched Alzheimer’s Society’s Dementia Connect service in seven of its pharmacies.
CPS wants the new MAS to move away from the current model to a more "activity-based" one.
Invatech Health's newly accredited Titan PMR is now available to pharmacies in England and Wales.
The head of LloydsPharmacy’s parent company has hit out at government business rates.
A pharmaceutical company has offered to pay the NHS £8m following an investigation into suspected collusion.
Community pharmacy contractors in England are being told by PSNC that they need to register for the MYS application.
The head of LloydsPharmacy’s parent company criticises the doubling of rent on one of its branches.
A disorderly no deal would disrupt the UK’s chemical and pharmaceutical supply chains overnight.